Generalized Anxiety Disorder Treatment Market
According to report by IMARC Group, the report provides the key factors driving the advancement in treatment of Generalized Anxiety Disorder. The increasing cases of imbalances or irregularities in certain neurotransmitters, like serotonin, norepinephrine, dopamine, etc., are primarily driving the market.